Private Advisor Group, LLC Novartis Ag Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Private Advisor Group, LLC holds 39,056 shares of NVS stock, worth $4.27 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
39,056
Previous 38,448 1.58%
Holding current value
$4.27 Million
Previous $4.09 Million 9.75%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$106.13 - $120.89 $64,527 - $73,501
608 Added 1.58%
39,056 $4.49 Million
Q2 2024

Aug 05, 2024
BUY
$92.57 - $107.37 $97,753 - $113,382
1,056 Added 2.82%
38,448 $4.09 Million
Q1 2024

Apr 30, 2024
SELL
$95.27 - $108.47 $22,197 - $25,273
-233 Reduced 0.62%
37,392 $3.62 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $121,796 - $134,032
-1,320 Reduced 3.39%
37,625 $3.8 Million
Q3 2023

Nov 02, 2023
BUY
$94.73 - $105.13 $71,426 - $79,268
754 Added 1.97%
38,945 $3.97 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $49,128 - $55,707
-531 Reduced 1.37%
38,191 $3.85 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $436,883 - $506,649
-5,459 Reduced 12.36%
38,722 $3.56 Million
Q4 2022

Jan 18, 2023
BUY
$75.55 - $92.52 $39,890 - $48,850
528 Added 1.21%
44,181 $0
Q3 2022

Oct 14, 2022
SELL
$74.61 - $87.26 $2.65 Million - $3.1 Million
-35,474 Reduced 44.83%
43,653 $3.32 Million
Q2 2022

Jul 13, 2022
BUY
$80.52 - $93.75 $523,541 - $609,562
6,502 Added 8.95%
79,127 $6.69 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $267,006 - $302,036
3,333 Added 4.81%
72,625 $6.37 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $1.62 Million - $1.8 Million
-20,386 Reduced 22.73%
69,292 $6.06 Million
Q3 2021

Oct 14, 2021
BUY
$81.78 - $95.14 $3.3 Million - $3.84 Million
40,356 Added 81.82%
89,678 $7.34 Million
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $441,117 - $487,226
5,175 Added 11.72%
49,322 $4.5 Million
Q1 2021

Apr 22, 2021
BUY
$83.5 - $98.47 $6,262 - $7,385
75 Added 0.17%
44,147 $3.77 Million
Q4 2020

Apr 01, 2021
BUY
$78.07 - $94.43 $532,671 - $644,295
6,823 Added 18.32%
44,072 $4.16 Million
Q3 2020

Nov 02, 2020
BUY
$82.14 - $91.0 $9,528 - $10,556
116 Added 0.31%
37,249 $3.24 Million
Q2 2020

Aug 17, 2020
BUY
$80.93 - $91.1 $440,016 - $495,310
5,437 Added 17.15%
37,133 $3.24 Million
Q1 2020

May 12, 2020
SELL
$70.67 - $99.01 $79,150 - $110,891
-1,120 Reduced 3.41%
31,696 $2.61 Million
Q4 2019

Feb 10, 2020
SELL
$84.35 - $95.37 $187,172 - $211,626
-2,219 Reduced 6.33%
32,816 $3.11 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $619,993 - $683,196
7,248 Added 26.08%
35,035 $3.05 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $19,227 - $23,664
255 Added 0.93%
27,787 $2.54 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $64,473 - $73,744
-856 Reduced 3.02%
27,532 $2.65 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $250,959 - $279,442
3,407 Added 13.64%
28,388 $2.44 Million
Q3 2018

Nov 01, 2018
BUY
$66.94 - $77.43 $676,964 - $783,049
10,113 Added 68.02%
24,981 $2.15 Million
Q2 2018

Aug 09, 2018
SELL
$64.91 - $73.36 $151,370 - $171,075
-2,332 Reduced 13.56%
14,868 $1.11 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $116,495 - $139,268
1,655 Added 10.65%
17,200 $1.39 Million
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $793,677 - $851,943
-10,973 Reduced 41.38%
15,545 $1.33 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $201,957 - $210,483
2,724 Added 11.45%
26,518 $2.27 Million
Q2 2017

Aug 10, 2017
BUY
N/A
23,794
23,794 $1.96 Million

Others Institutions Holding NVS

# of Institutions
1,433
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email